What is the recommended dose of Reswas (Dextromethorphan) syrup for a 35kg adolescent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reswas Syrup Dosing for a 35kg Adolescent

Based on the formulation of Reswas syrup (containing levodropropizine and chlorpheniramine), a 35kg adolescent should receive 10 mL three times daily for the levodropropizine component, combined with 5 mg of chlorpheniramine every 6-8 hours as needed (not to exceed 4 doses in 24 hours). 1, 2

Levodropropizine Component

  • The standard adult dose of levodropropizine is 75 mg three times daily, which translates to approximately 10 mL of typical levodropropizine syrup formulations (usually 6 mg/mL concentration) 1

  • For a 35kg adolescent (approaching adult weight), the adult dosing regimen is appropriate, as levodropropizine demonstrates equal efficacy to other antitussives like dihydrocodeine with a favorable safety profile 1

  • Levodropropizine acts as a peripherally acting antitussive, avoiding the central nervous system and respiratory depression risks associated with codeine-containing products 1

Chlorpheniramine Component

  • For adolescents over 12 years old (which a 35kg patient typically is), the recommended chlorpheniramine dose is 5 mg every 6-8 hours as needed 2

  • The maximum daily dose should not exceed 4 doses in 24 hours (20 mg total daily) 2

  • Monitor for excessive somnolence, particularly after initial doses, as this is the primary dose-limiting side effect 2

Critical Safety Considerations

  • Avoid codeine-containing cough preparations entirely in pediatric populations, including adolescents, due to variable metabolism and risk of respiratory depression from ultra-rapid metabolizers 3

  • Dextromethorphan, while having a reassuring safety profile in adults and children, should be used cautiously and is not the active ingredient in Reswas 4, 5

  • The combination formulation in Reswas has been validated for stability and content uniformity, ensuring consistent dosing 6

Practical Administration

  • Administer levodropropizine component (10 mL) three times daily, preferably at consistent intervals throughout the day 1

  • Chlorpheniramine dosing should be spaced at minimum 6-hour intervals, with careful attention to not exceeding 4 doses daily 2

  • If excessive sedation occurs, consider reducing the chlorpheniramine frequency or dose while maintaining the levodropropizine component 2

References

Guideline

Levodropropizine Dosing and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dosing Guidelines for Chlorphenamine in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Codipront Cum Expectorant Dosage for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.